Elim Pediatric Pharmaceuticals Inc. is a company based on corporate honesty, reliability and compliance in its drug product development plans. ElimPP Inc. was originally formed in 1999 under the name of Globalfarma International. Inc. The mission then was to consult, develop and distribute pharmaceuticals. The name was changed in 2008 and focus became sharpened to develop quality drug products for children’s diseases.

The founder of Elim Pediatric Pharmaceuticals Inc. is dedicated to development of children’s medication and has over 30 years in the understanding and development of quality pharmaceuticals. ElimPP Inc. is also committed to education in an effort to develop pediatric pharmaceuticals driven by science and patient-focused. The ultimate goal is to make drugs used to treat children diseases (such as such as HIV/AIDS, malaria and cancer) accessible to children anywhere in the world.

Mission
To provide highest quality drug products (branded or generic,) for treatment of various diseases in children.
Vision
Elim Pediatric Pharmaceuticals strives to have a significant influence in quality drug product development and global healthcare for children.

Investors
We are seeking investors that can partner with us in providing drug products that are specially designed to suit children and their needs

Facts about Elim
Professor Olusola Adeyeye
Chief Executive Officer, Elim Pediatric Pharmaceuticals Inc.
Professor Mojisola Christianah Adeyeye
Founder, President and Chief Scientist, Elim Pediatric Pharmaceuticals Inc.
Mr. Adesola Amosun
Engineer, Technical and Business Development
Mr. Temi Adeyeye
Consultant Engineer, Industry Assessment

Governance
Dr. Tobi Amosun
Pediatrician, Children’s Hospital, Pittsburgh, PA
Mrs. Ibie Falcusan
Attorney, Employment and Labor, Buchanan Ingersoll & Rooney PC, Washington DC
Other members to be announced

Articles of Incorporation and By Laws
Please click here to view the Articles of Incorporation